Lipoprotein-associated phospholipase A2 and aortic stenosis: biomarker or new target for an old foe?

JACC Cardiovasc Imaging. 2015 Jan;8(1):34-36. doi: 10.1016/j.jcmg.2014.11.001.

Authors

Donald Heistad¹, Hardik Doshi²

Affiliations

¹ Department of Internal Medicine, University of Iowa College of Medicine, Iowa City, Iowa; Department of Pharmacology, University of Iowa College of Medicine, Iowa City, Iowa; Department of Molecular, Cellular, and Developmental Biology, University of Colorado, Boulder, Colorado. Electronic address: donald-heistad@uiowa.edu.
² Department of Internal Medicine, University of Iowa College of Medicine, Iowa City, Iowa.

No abstract available

Keywords: Doppler echocardiography; aortic stenosis; calcific aortic valve disease; lipoprotein-associated phospholipase A2.

Publication types

Editorial
Comment

MeSH terms

1-Alkyl-2-acetylglycerophosphocholine Esterase / blood*
Aortic Valve Stenosis / blood*
Aortic Valve Stenosis / physiopathology*
Female
Humans
Male

Substances

1-Alkyl-2-acetylglycerophosphocholine Esterase

Grants and funding

P01 HL062984/HL/NHLBI NIH HHS/United States